Review

Insights on Nefecon®, a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy

Barratt J, Kristensen J, Pedersen C, Jerling M

Drug Design, Development and Therapy 2024, 18:3415-3428

Published Date: 31 July 2024